智通财经APP讯,复星医药(600196.SH)发布公告,公司控股子公司苏州二叶制药有限公司就复方匹可硫酸钠颗粒的上市注册申请于近日获国家药品监督管理局批准。该药品主要用于结肠镜检查、X射线检查前的肠道清洁准备,用于必要时在外科手术前清洁肠道。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.